I. Up-to-date viral hepatitis in Japan
نویسندگان
چکیده
منابع مشابه
Dynamic epidemiology of acute viral hepatitis in Japan.
The epidemiology of acute viral hepatitis (AVH) is dynamic and affected by many factors including hygiene, socioeconomic status and vaccination coverage. A total of 4,302 cases of AVH were sequentially enrolled in this nationwide study between 1980 and 2008. Of the cases of AVH, acute hepatitis A (AHA) accounted for 1,583 (36.8%), acute hepatitis B (AHB) for 1,197 (27.8%), acute hepatitis C (AH...
متن کاملPast, Present, and Future of Viral Hepatitis C in Japan
Of all the industrialized countries of the world, Japan has the highest rate of hepatitis C. It also has 1 of the oldest and most varied histories of hepatitis C in the world among the industrialized modern nations. Hepatitis C and its complications are the leading cause of liver cancer in Japan. Japan has the highest rate of liver cancer among the industrialized countries. From 2004 to 2014, P...
متن کاملUp to date in inhalation anaesthesia: desflurane
Background Inhaled volatile anaesthetics remain the most widely used drugs for maintenance of general anaesthesia because of their ease of administration and predictable intraoperative and recovery characteristics. The result has been an increasing reliance on fluorinated anesthetics. The most recently introduced anesthetics, desflurane and sevoflurane, are ethers halogenated solely with fluori...
متن کاملKeeping up to date in general practice.
detail and specific items such as the number of hospital referrals can be extracted fairly quickly by going down the appropriate column, in this case H, on each page. The material contained on the sheets can be used again by rearranging them. As an example, in this survey they were re-arranged in households by class and similar re-arrangements could be continued indefinitely. The flexibility is...
متن کاملViral Hepatitis 1 VIRAL HEPATITIS
1. Distinguish among viral hepatitis A, B, C, D, and E’s virology, epidemiology, and serological response to infection and clinical manifestation. 2. Design a prophylactic and therapeutic plan identifying the risk factors associated with the transmission of viral hepatitis A, B, C, D, or E in a clinical situation. 3. Develop an appropriate prophylactic regimen for preventing viral hepatitis A, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2018
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.107.10